Pharmacokinetics, tolerability and effects on intestinal flora of multiple ascending doses of tigecycline in male Japanese volunteers

Trial Profile

Pharmacokinetics, tolerability and effects on intestinal flora of multiple ascending doses of tigecycline in male Japanese volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jan 2014

At a glance

  • Drugs Tigecycline (Primary)
  • Indications Community-acquired pneumonia; Diabetic foot ulcer; Intra-abdominal infections; Methicillin-resistant Staphylococcus aureus infections; Nosocomial pneumonia; Skin and soft tissue infections
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 05 Jan 2014 New trial record
    • 18 Nov 2013 Results published in the Journal of Clinical Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top